Drug Type Small molecule drug |
Synonyms Anhydrous lithium citrate, Citric acid, trilithium salt, Lithium citrate (anhydrous) + [8] |
Target |
Mechanism BACE1 inhibitors(Beta-secretase 1 inhibitors), GSK-3β inhibitors(Glycogen synthase kinase-3 beta inhibitors), Neurons modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date US (23 Dec 1980), |
Regulation- |
Molecular FormulaC6H16Li3O11 |
InChIKeyIJICAEDBCROIST-UHFFFAOYSA-N |
CAS Registry6080-58-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04749 | Lithium Citrate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bipolar Disorder | US | 23 Dec 1980 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 2 | FR | 20 May 2022 |